Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Atricure Inc. buy BTIG Research

Start price
€27.40
18.02.26 / 50%
Target price
€45.59
18.02.27
Performance (%)
0.00%
Price
€27.40
18.02.26
Summary
This prediction is currently active. The BUY prediction by BTIG_Research is currently unchanged from the start price. This prediction currently runs until 18.02.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this prediction
Performance without dividends (%)
Name 1w
Atricure Inc. 0.00%
iShares Core DAX® 0.193%
iShares Nasdaq 100 -1.353%
iShares Nikkei 225® -0.426%
iShares S&P 500 -1.008%

Comments by BTIG_Research for this prediction

In the thread Atricure Inc. diskutieren
Prediction Buy
Perf. (%) 0.00%
Target price 45.587
Change
Ends at 18.02.27

AtriCure (NASDAQ:ATRC) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $54.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat

Stopped prediction by BTIG_Research for Atricure Inc.

buy
Atricure Inc.

Start price
Target price
Perf. (%)
€27.40
31.07.24
€48.94
31.07.25
-
01.08.25